Rock Springs Capital Management’s Cymabay Therapeutics CBAY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-900,000	Closed	-$4.61M	–	141
2019 Q3	$4.61M	Hold	900,000	–	–	0.18%	107
2019 Q2	$6.44M	Buy	900,000 +185,000	+26%	+$2.09M	0.24%	92
2019 Q1	$9.49M	Buy	715,000 +101,396	+17%	+$1.08M	0.37%	84
2018 Q4	$4.83M	Hold	613,604	–	–	0.23%	97
2018 Q3	$6.8M	Buy	613,604 +33,604	+6%	+$417K	0.25%	101
2018 Q2	$7.78M	Buy	580,000 +90,000	+18%	+$1.13M	0.3%	97
2018 Q1	$6.37M	Buy	490,000 +40,000	+9%	+$497K	0.27%	102
2017 Q4	$4.14M	Hold	450,000	–	–	0.19%	113
2017 Q3	$3.63M	Buy	+450,000	New	+$3.04M	0.17%	113
2015 Q1	–	Sell	-100,000	Closed	-$983K	–	109
2014 Q4	$983K	Sell	100,000 -200,000	-67%	-$1.61M	0.12%	92
2014 Q3	$2.05M	Buy	+300,000	New	+$1.84M	0.32%	75